AU7295696A - Pharmaceutical composition for treating osteoporosis - Google Patents
Pharmaceutical composition for treating osteoporosisInfo
- Publication number
- AU7295696A AU7295696A AU72956/96A AU7295696A AU7295696A AU 7295696 A AU7295696 A AU 7295696A AU 72956/96 A AU72956/96 A AU 72956/96A AU 7295696 A AU7295696 A AU 7295696A AU 7295696 A AU7295696 A AU 7295696A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- treating osteoporosis
- osteoporosis
- treating
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US596695P | 1995-10-27 | 1995-10-27 | |
US005966 | 1995-10-27 | ||
PCT/EP1996/004532 WO1997016193A1 (en) | 1995-10-27 | 1996-10-18 | Pharmaceutical composition for treating osteoporosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7295696A true AU7295696A (en) | 1997-05-22 |
Family
ID=21718613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU72956/96A Abandoned AU7295696A (en) | 1995-10-27 | 1996-10-18 | Pharmaceutical composition for treating osteoporosis |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR003089A1 (es) |
AU (1) | AU7295696A (es) |
WO (1) | WO1997016193A1 (es) |
ZA (1) | ZA969021B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU733970B2 (en) * | 1996-05-23 | 2001-05-31 | F. Hoffmann-La Roche Ag | Fluorinated vitamin D3 analogs |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939408A (en) | 1996-05-23 | 1999-08-17 | Hoffman-La Roche Inc. | Vitamin D3 analogs |
ES2192136B1 (es) * | 2002-01-04 | 2005-03-16 | Italfarmaco, S.A. | Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis. |
CN114588176B (zh) * | 2022-02-15 | 2024-01-23 | 许静宜 | 一种研究麦冬皂苷d促进骨质疏松h型血管方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
DK0580968T3 (da) * | 1992-05-20 | 1996-10-14 | Hoffmann La Roche | Fluorerede analoger af vitamin D3 |
-
1996
- 1996-10-18 AU AU72956/96A patent/AU7295696A/en not_active Abandoned
- 1996-10-18 WO PCT/EP1996/004532 patent/WO1997016193A1/en active Application Filing
- 1996-10-24 AR ARP960104895A patent/AR003089A1/es unknown
- 1996-10-25 ZA ZA9609021A patent/ZA969021B/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU733970B2 (en) * | 1996-05-23 | 2001-05-31 | F. Hoffmann-La Roche Ag | Fluorinated vitamin D3 analogs |
Also Published As
Publication number | Publication date |
---|---|
AR003089A1 (es) | 1998-07-08 |
ZA969021B (en) | 1998-04-28 |
WO1997016193A1 (en) | 1997-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802086A3 (en) | Pharmaceutical composition for piperidinoalkanol compounds | |
AU1128297A (en) | Composition for treating pain | |
AU6216296A (en) | Pharmaceutical compositions | |
HU9601698D0 (en) | Pharmaceutical composition | |
AU1139095A (en) | Combination treatment for osteoporosis | |
AU6904896A (en) | Pharmaceutical compounds | |
IL118590A (en) | Pharmaceutical composition for minimizing bone loss | |
AU5155096A (en) | Pharmaceutical composition | |
ZA964373B (en) | A pharmaceutical composition for treating lukemia | |
GB9519667D0 (en) | Pharmaceutical composition | |
ZA963590B (en) | Pharmaceutical composition | |
AU5274096A (en) | Pharmaceutical compositions | |
ZA9610426B (en) | Pharmaceutical composition | |
ZA961051B (en) | Pharmaceutical composition | |
ZA964193B (en) | Pharmaceutical composition | |
AU7295696A (en) | Pharmaceutical composition for treating osteoporosis | |
IL118573A (en) | Pharmaceutical compositions for minimizing bone loss | |
AU6814496A (en) | Pharmaceutical composition | |
ZA963591B (en) | Pharmaceutical composition | |
ZA95736B (en) | Pharmaceutical composition | |
AU723097C (en) | Pharmaceutical composition | |
AU741226C (en) | Pharmaceutical composition | |
ZA961389B (en) | Pharmaceutical composition for piperidinoalkanol compounds | |
SI0812195T1 (en) | Pharmaceutical composition for piperidinoalkanol compounds | |
ZA968383B (en) | Composition for treatment of osteoporosis. |